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Abstract 
Watery mouth disease is a considered to be a significant cause of neonatal mortality in 
lambs.  The clinical signs are strongly associated with an endotoxaemia produced as a 
result of the lysis of gram-negative bacteria.  It has been associated with mass antibiosis 
to neonatal lambs at birth, a practice which is now untenable.  It can be prevented in many 
cases through the timely administration of good quality colostrum and a hygienic birth 
environment.  However, despite this, much remains unknown about the specific 
aetiopathogenesis.  Alternative strategies for prevention, treatment and control are 
required, particularly when colostrum quality is poor, or delivery is absent, and where 
unhygienic conditions predominate.   
 
Introduction 
The mortality and morbidity of neonatal lambs is a cause of poor welfare for affected 
cases and results in the reduced production and economic profitability of farms.  
Worldwide, on average, 15% of lambs die in the neonatal period with this rate remaining 
unchanged for the past 40 years (Dwyer and others 2016).  Following birth, the neonate 
enters a new and hostile environment compared to that in utero and in particular must 
meet the challenge presented by infectious organisms which very rapidly become 
important causes of mortality for neonatal lambs.  In recent surveys, infectious disease 
accounted for 10% of neonatal deaths in Wales, UK (HCC 2011) and 36% in Norway 
(Holmoy and others 2016), with both surveys reporting the majority of deaths within 48 
hours of birth.  Arguably, the most important infectious disease syndrome reported in 
this very early period is an endotoxaemia associated with undefined pathotypes of 
Escherichia coli, colloquially known as watery mouth disease (WM) on account of one of 
the clinical signs seen – drooling saliva from the mouth.   
 
Although WM has been recognised since at least the 1920s (Eales 1987) surveys have 
suggested in intensively farmed sheep it can account for of up to a quarter of all neonatal 
deaths (King and Hodgson 1991; Scott 2007).  Together with this, WM is cited as the 
biggest reason for the widespread prophylactic and metaphylactic use of antibiotics, in 
large numbers of flocks in some regions (Davies and others 2017; King and Hodgson 
1991).  This practice is clearly untenable, in particular in light of the integrated global 
challenges of improving food security, maintaining and improving animal welfare and 
reducing the use of antimicrobials in farmed species (O'Neill 2016; WHO 2015).  Watery 
mouth disease has for too long been neglected from a research perspective, and 
alternatives to mass antibiosis are urgently required.   
 
The aim of this review is to summarise the current knowledge of WM in lambs and clarify 
the evidence base for each aspect considered.   
 
Materials and Methods 
Due to the small numbers of research papers published on WM, a broad systematic 
approach was used to try and identify as many peripheral studies, letters and reports as 
possible (Figure 1).  Three English language databases were utilised: PubMed, Web of 
Science and Scopus over the time frame 1980-2019 inclusive.  These databases were 
searched using predefined search terms (Table 1).  The citations were primarily 
screened for eligibility by title and abstract and the full text used for any ambiguous 
citations.   
 











































Figure 1: Prisma flow diagram indicating the number of citations at each stage of the systematic 
review process.  From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS 
Med 6(7): e1000097. doi:10.1371/journal.pmed1000097.  For more information, visit www.prisma-
statement.org. 
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Database and search terms used N citations 
PubMed – 29/11/2019  
“watery mouth”[Title/Abstract] 14 
(endotoxic[Title/Abstract] AND lambs[Title/Abstract] 2 
(endotoxaemia[Title/Abstract]) AND lambs[Title/Abstract] 5 
(endotoxin[Title/Abstract]) AND lambs[Title/Abstract] 66 
(((Escherichia coli[Title/Abstract]) OR E. coli[Title/Abstract])) AND 
Lambs[Title/Abstract] 
201 
Web of Science - 29/11/2019  
(TS="watery mouth") AND LANGUAGE: (English)) 21 
(TS=(endotoxic AND lambs) AND LANGUAGE: (English)) 6 
(TS=(endotoxaemia AND lambs) AND LANGUAGE: (English))  8 
(TS=(endotoxin AND lambs) AND LANGUAGE: (English)) 209 
(TS=((Escherichia coli OR E. coli) AND lambs)) AND LANGUAGE: (English)) 839 
Scopus – 29/11/2019  
TITLE-ABS-KEY ("watery mouth") 20 
TITLE-ABS-KEY (endotoxic AND lambs) 4 
TITLE-ABS-KEY (endotoxaemia AND lambs) 6 
TITLE-ABS-KEY (endotoxin AND lambs) 95 
TITLE-ABS-KEY ((Escherichia coli OR E. coli) AND lambs) 970 
 
Table 1: Databases and search terms used in the systematic review process, together 
with the number of citations identified from each individual search.   
 
Citations were excluded for the following reasons: 
• If duplicated. 
• If not written in English and a suitable translation was unavailable.   
• If considered irrelevant in terms of the disease process or body system considered 
e.g. excluded if the study considered solely the respiratory system.   
• If solely considered pre-term lambs or lambs older than 7 days.   
• If primarily investigating the LamB protein in E. coli.   
 
Following the initial screening process a further 60 full-text articles were examined and 
removed.  Throughout this process a small number of additional articles (n=23) not 
identified through the original database searches were found by searching the reference 





Twenty four citations were obtained that described clinical features of WM (Table 2) and 
of these 15 specified a case definition.  Increased salivation/mucus around the mouth was 
the only feature described by all 24 publications, 17 described cases as having reduced 
appetite or ceasing to suck, 17 described cases as having a distended 
abdomen/abdominal tympany and 15 described cases as dull or depressed.  Other 
features were less frequently reported although in some citations were considered as key 
features of the disease e.g. retained meconium or reduced gut motility (Mitchell and 
Linklater 1983).   
 
In summary, the disease usually manifests in lambs <72 hours of age usually presenting 
as dull/depressed with reduced sucking/inappetence followed by the development of 
increased salivation/mucus around the mouth and hence the name ‘watery mouth’ 
(Figure 2, a) and b)).  This feature has also led to the synonymous colloquialisms: 
slavers/slavery mouth (King 1986; King and Hodgson 1991); two French reviews use the 
colloquialisms ‘agneaux baveurs’ (slobbery lambs) and ‘bouche baveuse’ (slobbery 
mouth) (Millemann and others 2003; Poncelet 2004).  Abdominal tympany appears later 
on in the disease process (Figure 2, image c)) and several authors describe that gentle 
shaking of these lambs elicits a splashing sound hence a further colloquialisation ‘rattle 
belly’ (Eales 1987; Haig 1981; King 1986).  Scouring is unusual and often constipation or 
retained meconium may be present (Eales and others 1986).  Untreated cases die within 
six to 24 hours showing a terminal hypoglycaemia, hypothermia and lacticacidaemia 






Figure 2: Clinical signs associated with watery mouth disease; a) and b) two lambs with 
signs of increased salivation around the mouth; c) a lamb with right sided abdominal 
distension associated with abdominal tympany; d) post mortem dissection clearly showing 





c) b) a) 
d) 
 
Table 2: Specific clinical signs of clinical cases with watery mouth as described or reported by publications, together with those that described the clinical feature as part of a specific case definition.   
Clinical feature 










Christodoulopoulos (2008); Christodoulopoulos and others (2013); Collins (1981); 
Collins and others (1985); Eales (1987); Eales and others (1986); Eales and others 
(1985); Findlay (1973); Haig (1981); Hodgson (1993); Hodgson and others (1995); 
Hodgson and others (1999); Hodgson and others (1989a); Hodgson and others 
(1989b); King (1986); King and Hodgson (1991); Linklater (1989); Millemann and 
others (2003); Mitchell and Linklater (1983); Orr (1995); Poncelet (2004); Scott 
(1988); Scott and Gessert (1996); Vaid (1991) 
24 
Christodoulopoulos (2008); Christodoulopoulos and 
others (2013); Eales (1987); Eales and others (1986); Eales 
and others (1985); Findlay (1973); Hodgson and others 
(1995); Hodgson and others (1989a); Hodgson and others 
(1989b); King (1986); King and Hodgson (1991); Mitchell 
and Linklater (1983); Scott (1988); Scott and Gessert 





Eales (1987); Eales and others (1986); Eales and others (1985); Findlay (1973); 
Hodgson (1993); Hodgson and others (1995); Hodgson and others (1999); Hodgson 
and others (1989a); Hodgson and others (1989b); King (1986); King and Hodgson 
(1991); Linklater (1989); Mitchell and Linklater (1983); Sargison and others 
(1997); Scott (1988); Scott and Gessert (1996); Vaid (1991) 
17 
Eales (1987); Eales and others (1986); Eales and others 
(1985); Findlay (1973); Hodgson and others (1995); 
Hodgson and others (1989a); Hodgson and others (1989b); 
King (1986); King and Hodgson (1991); Mitchell and 
Linklater (1983); Scott (1988); Scott and Gessert (1996); 
Vaid (1991) 
13 
Distension of the 
abdomen or abdominal 
tympany 
Christodoulopoulos and others (2013); Collins and others (1985); Eales (1987); 
Eales and others (1986); Findlay (1973); Haig (1981); Hodgson (1993); Hodgson 
and others (1989a); Hodgson and others (1989b); King (1986); King and Hodgson 
(1991); Linklater (1989); Mitchell and Linklater (1983); Sargison and others 
(1997); Scott (1988); Scott and Gessert (1996); Vaid (1991) 
17 
Christodoulopoulos and others (2013); Findlay (1973); 
Hodgson and others (1989a); Hodgson and others (1989b); 
King (1986); Mitchell and Linklater (1983); Scott (1988); 
Scott and Gessert (1996); Vaid (1991) 
9 
Dull/depressed Eales (1987); Eales and others (1986); Eales and others (1985); Haig (1981); 
Hodgson (1993); Hodgson and others (1995); Hodgson and others (1999); Hodgson 
and others (1989a); Hodgson and others (1989b); King (1986); King and Hodgson 
(1991); Linklater (1989); Mitchell and Linklater (1983); Sargison and others 
(1997); Vaid (1991) 
15 
Eales (1987); Eales and others (1986); Eales and others 
(1985); Goelst and others (1992); Hodgson and others 
(1995); Hodgson and others (1989a); Hodgson and others 
(1989b); King (1986); King and Hodgson (1991); Vaid 
(1991) 
10 
Usually in lambs <72 
hours old 
Christodoulopoulos (2008); Christodoulopoulos and others (2013); Collins and 
others (1985); Eales (1987); Haig (1981); Hodgson (1993); King and Hodgson 
(1991); Linklater (1989); Poncelet (2004) 
9 
Christodoulopoulos (2008); Christodoulopoulos and 
others (2013); Eales (1987); King and Hodgson (1991) 4 
Retained 
meconium/constipation 
Collins (1981); Findlay (1973); Gilmour and others (1985); Haig (1981); King and 
Hodgson (1991); Linklater (1989); Mitchell and Linklater (1983); Scott (1988); 
Winkler (1981) 
9 




Eales and others (1985); Hodgson (1993); Hodgson and others (1989a); Hodgson 
and others (1989b); Linklater (1989); Mitchell and Linklater (1983); Vaid (1991) 
7 
Hodgson and others (1989a); Hodgson and others (1989b); 




Collins and others (1985); Findlay (1973); Hodgson and others (1999); King and 
Hodgson (1991); Sargison and others (1997); Scott (1988) 
6 
Findlay (1973); Scott (1988) 
2 
Lethargy Christodoulopoulos and others (2013); Collins and others (1985); Linklater (1989); 
Scott (1988); Scott and Gessert (1996) 
5 
Christodoulopoulos and others (2013); Scott (1988); Scott 
and Gessert (1996) 
3 
Mostly normothermic Collins and others (1985); Eales (1987); Eales and others (1986); Linklater (1989); 




Mostly not scouring Collins and others (1985); Eales and others (1986); Gilmour and others (1985); King 




Increased lacrimation Hodgson (1993); Hodgson and others (1999); King and Hodgson (1991) 3   
Usually scouring Hodgson and others (1999) 1   
Congested mucous 
membranes 





Many cachectic lambs will salivate in extremis (Linklater 1989) but usually less so 
than those with WM, so in the terminal stages of disease diagnosis may be more 
difficult.  However, in earlier stages of the disease and by observing the 
progression of individual cases diagnosis presents few difficulties.  Diagnosis may 
be clarified post mortem where abomasal distension with gas and saliva together 
with a possible retained meconium may be observed (Carson 2019).   
 
Differential diagnoses include colibacillosis (neonatal lamb diarrhoea) and lamb 
dysentery (Mitchell and Linklater 1983; Sargison 2008b), ‘salivary abomasum 
disease’ (SAD) (Christodoulopoulos and others 2013) and ‘lamb D-lactic acidosis 
syndrome’ (LDLAS) (also known as ‘drunken lamb syndrome’ (DLS)) (Angell and 
others 2013).  These diseases can usually be differentiated clinically from WM by 
careful observation of the progression of the disease and the clinical signs seen.   
 
Lamb dysentery manifests as the sudden death of young lambs, usually up to 10 
days of age, and more slowly developing cases may produce profuse volumes of 
blood stained diarrhoea, although death may occur too rapidly for this to be 
observed (Sargison 2008b).  At post mortem these lambs classically have obvious 
haemorrhages in the small intestine (Figure 3) and epsilon toxin may be 
identified.   
 
Lambs affected with SAD tend to be older than those with WM (mean age 7.23 
days (SD 3.14)), and do not present with clinical or biochemical signs of endotoxic 
shock (Christodoulopoulos and others 2013).  It has been suggested that SAD is 
possibly equivalent to WM but presents differently due to the increased age of the 
lambs (Christodoulopoulos 2008).  To the authors’ knowledge there has only been 
one study of SAD to-date and more research is needed to identify the key 
similarities and differences between SAD and WM.   
 
 
Figure 3: Haemorrhagic fluid distending the jejunum of a lamb with lamb 
dysentery.  Diarrhoea evident staining the perineum.   
 
Some clinical signs are shared between lambs with WM and those with LDLAS, 
however those with LDLAS also tend to be older - approximately 2 weeks of age, 
and do not present with hyper-salivation.  Enteritis was noted in 2/10 cases of 
LDLAS together with nephrotic changes in all 10 cases, however endotoxaemia 
was not a feature of the biochemical values (Angell and others 2013).  
Furthermore, whilst acidosis is a feature of LDLAS and possibly SAD, an alkalosis 
has been observed in some cases of WM (Scott and Gessert 1996) until the latter 
stages when a metabolic acidosis results (Hodgson and others 1989b).   
 
 
Biochemical and haematological data 
The mean biochemical and haematological data reported by Eales and others 
(1986) revealed no abnormalities, and similar findings were demonstrated by 
Scott and Gessert (1996).  However, in an experimental model, plasma lactate, and 
urea concentrations increased significantly in cases compared to controls towards 
the terminal stages of disease and plasma glucose, total protein (mostly the 
globulin component) and the number of white blood cells decreased significantly 
in cases compared to controls (Hodgson and others 1995; Hodgson and others 
1989b).   
 
Pathology 
Only one systematic study of pathological changes in lambs with WM was 
identified - Gilmour and others (1985) - and the results from these 38 lambs are 
summarised in  
Table 3.  Enteritis was a feature of the disease in 25 out of 38 cases (66%), 
although the causal nature cannot be ascertained due to the cross-sectional nature 
of the study.  Retained meconium was only present in 12 (32%) and the changes 
seen in the liver, lung and nervous system appear incidental compared to the 
changes observed in the alimentary tract.  In this study there was no correlation 
between WM and low colostrum absorption, although immunoglobulins were not 
assessed by methods other than histology.  In the study by Collins and others 
(1985) lower values of immunoglobulin G may have been associated with an 
increase in mortality, however there was wide variation within the small sample 
(n=23).  In a natural experimental model of infection 9/18 lambs developed WM 
and these were reported to have inflammation of the gastrointestinal tract (also 
distended with gas), pale kidneys and muscle, a dehydrated carcass and enlarged 
mesenteric lymph nodes (Hodgson and others 1999).  In a single case from New 
Zealand, the abomasum was pale, gas filled and contained a small milk clot and 
clear mucoid fluid.  The small intestine was also pale and gas filled and contained 
sparse contents.  The bladder serosa was congested and the pericardium 
contained 10ml of serous fluid (Sargison and others 1997).  Similarly, Shaw 
(1981) reports that the abomasum usually contains an excessive quantity of clear 
mucous, which may or may not be mixed with the colostrum/milk and there may 
be a retained meconium.   
 
In comparison, abomasal haemorrhages, abomasal bloat and the presence of 
excess saliva in the abomasum were a feature in cases of SAD and some also had 
nephrosis (Christodoulopoulos 2008), but neither abomasal haemorrhages or 
nephrosis were reported in the WM cases by Gilmour and others (1985).  In LDLAS 
the pathological picture was also different to WM with nephrosis a feature in all 
10 cases and mild enteritis only identified in 3/10 (Angell and others 2013).   
 
 
Table 3: Summary of pathological changes observed in 38 lambs with WM as reported by 
Gilmour and others (1985).  *N=38 unless otherwise specified.   
Body region/organ system and pathological change 
observed 
Number of lambs 
(Percentage of 
lambs*) 
External examination   
 External evidence of diarrhoea 11 (29) 
Rumen   
 pH (n=37) Mean 5.8 (SE 0.15) 
 Milk present 1 (3) 
 Watery content 37 (97) 
Abomasum   
 pH (n=38) Mean 3.9 (SE 0.15) 
 Milk/clots present 20 (53) 
 No milk present 18 (47) 
 Inflammatory changes present in mucosa 1 (3) 
 Bacteria isolated   
Small intestine   
 Empty 1 (3) 
 Liquid 37 (97) 
 Inflammatory changes present in mucosa (n=25) 12 (48) 
 Histological evidence of colostrum absorption 29 (76) 
Large intestine   
 Empty 1 (3) 
 Liquid 16 (42) 
 Firm 9 (24) 
 Meconium present 12 (32) 
 Inflammatory changes present in mucosa (n=25) 13 (52) 
 Inflammatory changes present in lambs with retained 
meconium (n=12) 
8 (67) 
Liver   
 Hepatitis associated with ascending umbilical infection 2 (5) 
 Fatty degeneration 4 (11) 
Lung   
 Suppurative broncho-pneumonia 1 (3) 
 Mild interstitial pneumonia 9 (24) 
 Retention of some fetal characteristics 4 (11) 
Nervous system   
 Mild non-suppurative meningoencephalitis 1 (3) 




In an observational study, Gilmour and others (1985) reported a bacteraemia at 
the point of euthanasia, with E. coli identified in 14/20 (70%) lambs and culture 
of abomasal and intestinal samples revealed coliform, clostridia and streptococcus 
species to be most prevalent.  In another observational study, positive bacterial 
cultures from blood samples obtained from 71 cases (38%) demonstrated 
coliforms (31%), Staphylococcus spp. (30%) and Bacillus spp. (20%) (Eales and 
others 1986).  A pure growth of E. coli (without the K99 antigen) was also 
identified from the small intestine, liver and pericardial fluid in a single case from 
New Zealand (Sargison and others 1997).   
 
In experimental studies, colostrum-deprived lambs reared in a contaminated 
environment were shown to frequently develop a bacteraemia within two - twelve 
hours of birth and a bacteraemia was a persistent feature of the lambs with WM 
compared to controls, with all the isolates identified as coliforms (Hodgson and 
others 1999; Hodgson and others 1992).  A bacteraemia was also demonstrated 
experimentally in gnotobiotic lambs experimentally inoculated by mouth using an 
E. coli strain isolated from a clinical case (Hodgson and others 1995).  However, 
this bacteraemia was more intermittent and of lower concentration (cfu/ml) in 
lambs given human endotoxin-core hyperimmune IgG prior to inoculation 
compared to those given a saline control.   
 
In comparison, E. coli were only cultured from 6/37 abomasal samples from cases 
of SAD (Christodoulopoulos and others 2013) and were found to be prevalent in 
cases of LDLAS (Angell and others 2013).   
 
Aetiology and Pathogenesis 
The specific aetiology of watery mouth is unknown and indeed there may not be 
a specific aetiological agent.  The pathogenesis so far has only partially been 
unravelled and there remain key gaps in our knowledge, however three key 
features appear pertinent and are likely to play a role in the pathogenesis: 1) the 
ingestion of E. coli from a contaminated environment, 2) the production of 
endotoxin and 3) a delay in abomasal emptying.   
 
Biochemical analysis has shown in both observational and experimental studies 
that endotoxins – possibly released as a result of lysis of large numbers of gram 
negative bacteria – play a role in the pathogenesis and are responsible for the 
majority of the clinical signs (Hodgson 1993; Hodgson and others 1995; Hodgson 
and others 1989a; Hodgson and others 1989b; Sosa and others 1994).  
Experimental work has shown that E. coli serotypes not currently considered 
‘pathogenic’ may cause the disease when orally inoculated into gnotobiotic lambs, 
however there have been no comprehensive bacterial surveys of the E. coli 
serotypes associated with watery mouth and it is currently unclear whether any 
E. coli can cause the symptoms seen, given the right conditions, or whether certain 
pathotypes are more commonly associated with disease.   
 
The effects of endotoxin are well studied and have been reviewed extensively by 
Hodgson (2006).  It can cause hypoglycaemia, reduce body temperature, depress 
appetite and induce gut stasis and lead to death via multiple critical organ failure 
(Hodgson 1993).  Specifically endotoxin has been shown to have the following 
effects on neonatal lambs: 
 
1. Effects on body temperature 
In three lambs aged 4-11 days, E. coli derived endotoxin was shown (P<0.05) to 
accelerate the rate of decline in summit metabolism – that is lambs found it harder 
to keep warm - compared to control lambs (Alexander 1970).  In another study, 
endotoxin derived from E. coli induced a smaller rise in temperature in lambs 
compared to ewes when administered intravenously (Coceani and others 1995) 
and additionally failed to elicit a significant change in temperature compared to 
saline treated control lambs (Goelst and others 1992).  These findings may explain 
why many lambs clinically appear normothermic with WM (Collins and others 
1985; Eales and others 1986).   
 
2. Effects on the cardiovascular system 
Sosa and others (1994) administered very large doses of E. coli derived endotoxin 
(0.5mg/kg) to neonatal lambs (aged 0-3 days) and studied the effects on 
ventricular contractility.  The mean arterial blood pressure decreased as a result 
of a decline in myocardial contractility.  The adverse effects were shown to be 
stabilised with saline boluses resulting in survival of these lambs compared to 
those that did not receive saline.  However, this study used much larger1 doses of 
                                                        
1  Working on a circulating blood volume of 60ml/kg (SWENSON, M. J. (1993) Physiological 
Properties and Cellular and Chemical Constituents of Blood. In Dukes' Physiology of Domestic 
Animals. 11 edn. Eds M. J. SWENSON, W. O. REECE. USA, Cornell University Press. p 45) and a 
weight of 4kg for a new born lamb, then a lamb may have an approximate circulatory volume of 60 
x 4 = 240ml of blood.  A dose of 0.5mg/kg is 4 x 0.5 = 2mg, therefore 2mg/240ml = 0.008mg/ml or 
8,000ng/ml.  This is approximately 33 times more than was observed in an experimental infection.   
endotoxin compared to the concentration observed (240ng/ml) as a result of 
experimental infection with orally inoculated E. coli (Hodgson and others 1989a) 
and therefore these effects of endotoxin are likely to be much less in a natural 
infection.  In a similar study Bech-Jansen and others (1972) did not show any 
change in arterial blood pressure, however the follow-up in that study was only 
for 30 minutes, which when compared to the study by Sosa and others (1994) was 
not long enough to detect an effect.  Feng and others (2010) showed that cerebral 
blood flow could be reduced following the administration of E. coli derived 
endotoxin, however again they used much higher doses (10 times) than may be 
detected in cases of watery mouth.  However, even a minor dysregulation of the 
cerebral blood flow could exacerbate clinical signs, accelerate decline and reduce 
the chances of recovery.   
 
There is good evidence for the role of endotoxins in WM. The administration of 
human IgG polyclonal antibody to endotoxin core prior to the intravenous infusion 
of E. coli was successful in preventing clinical, biochemical and haematological 
signs of WM in 5 lambs, compared to 3 control lambs infused with human plasma 
albumin (Hodgson and others 1995).  In that study, none of the five lambs 
pretreated with the polyclonal antibody developed signs of WM, but two out of 
three control lambs did.   
 
Delayed abomasal emptying has been observed clinically (Collins and others 
1985) and this was confirmed in an experimental study comparing 34 cases with 
WM with 68 healthy controls (Eales and others 1985).  In this study, contrast 
radiography with barium sulphate was used to compare the rate of abomasal 
emptying.  Delayed abomasal emptying was observed in healthy lambs aged 24-
48 hours, however gut tone and motility were depressed to a greater extent in the 
lambs with WM (P<0.05).  More recently, the acetaminophen absorption test was 
also used experimentally to investigate the effects of an infusion of endotoxin 
(2µg/kg) in lambs aged 1-3 weeks (Mozaffari and others 2018).  In that study, the 
mean CMAX, TMAX and AUC were lower (P<0.05) for the five treatment lambs 
compared to the five control lambs, suggesting delayed abomasal emptying as a 
result of the endotoxin.   
 
An aetiopathogenic hypothesis 
The integration of this evidence has led to the development of the following 
aetiopathogenic hypothesis:  
 
The abomasal contents of the newborn lamb is relatively neutral and the gut has 
relatively reduced motility - which may serve normally to assist in the uptake of 
colostrum derived immunoglobulins (Eales and others 1985; Leek 1993).  
Paradoxically, this may also allow the survival and growth of bacteria ingested 
from the environment, especially in the absence of colostrum, and this may be 
compounded by the effect of bacterial endotoxin.  The normal pinocytotic 
mechanisms, which exist for the first 24 hours of life to transport large molecules 
from the gut into the systemic circulation, may allow access by bacteria and result 
in a bacteraemia (Hodgson and others 1989a; Hodgson and others 1992).  Some 
bacteria may express factors that opportunistically assist in this process e.g. the 
aerobactin-mediated iron transport system (Der Vartanian and others 1992).  
Lysis en-masse of gram-negative bacteria may lead to large volumes of endotoxin 
resulting in an endotoxaemia and its clinical sequelae ( 
 
Figure 4) (Hodgson 1993; Hodgson and others 1989b; King and Hodgson 1991; 










Figure 4: A schematic diagram illustrating a proposed pathogenic hypothesis of the development of WMD.  The clinical signs and 
subsequent sequelae are then strongly associated experimentally and observationally with the endotoxaemia.   
 
Stage 2 Stage 1 
Epidemiology 
Frequency and distribution 
Watery mouth disease has been reported widely in the UK, but we are also aware 
of reports from France (including a similar condition in neonatal goat kids) 
(Poncelet 2004; Savey 1986), Spain (Garcia de Jalon and others 1990), Canada 
(Hodgson 1993), New Zealand (Orr 1995; Sargison and others 1997) and Norway 
(Phythian, C.J., 2016, personal communication).  It seems likely that it could occur 
anywhere where sheep are produced under intensive conditions.   
 
Accurate up-to-date data on prevalence or incidence rates at regional or national 
level are unavailable, however personal experience and numerous discussions 
with practitioners would suggest that WM is widespread, with large variations 
between farms and within farms from year to year.  Unpublished pilot work with 
one large UK veterinary practice in 2015 revealed that 64.6% of 895 farmers used 
some form of prophylactic/metaphylactic antibiotic medication to prevent or 
mitigate the losses caused by WM, implying that this proportion either currently 
see or have seen cases historically.  In addition, Davies and others (2017) reported 
47% (95%CI: 41-62%) of 207 flocks (convenience sample) located in England and 
Wales used licensed oral antibiotics for treatment/prophylaxis of colibacillosis, 
with a further 2 flocks prescribed oral antibiotic tablets.   
 
Historically, Collins and others (1985) reported an incidence rate on six farms of 
up to 3.1% and the mortality of affected cases as 41% - although mortality was 
observed to worsen with age of onset with those aged more than 48 hours when 
infected being less likely to recover.  Eales and others (1986) reported an 
incidence rate of up to 24% of lambs born and mortality of affected cases up to 
83%, however in this study there was large variation between the 11 farms with 
those farms with greater contact with the investigators (Woodhouselee, Glencorse 
and Longyester) reporting a higher incidence rate and lower mortality of affected 
cases compared to those with less contact (farms A-H).  The initial data reported 
by Scott (1988) suggests that in the control groups across eight farms, the 
incidence rate was reported to be up to 43% of lambs born at which point 
prophylactic therapy was instigated, and mortality of affected cases up to 25%, 
despite treatment.  Finally, Hodgson (1993) reported that from a survey of 170 
farmers owning 100,000 ewes WM was responsible for 23% of deaths among 
housed lambs.   
 
Factors associated with watery mouth 
Risk factors for watery mouth include increased litter size – triplets being at 
greater risk than twins (Collins and others 1985) and lambs from multiple litters 
more likely than from single litters (P<0.01) (Eales and others 1986).  Also, Eales 
and others (1986) reported smaller lambs to be slightly more at risk (p<0.05) 
although this difference was not observed in cases when compared to their 
healthy twin.  Additionally lambs born to ewes of poor condition were more at risk 
although there may have been some confounding by, or interaction with age, 
which was also associated - lambs were more at risk when born to ewes aged one 
or five years but at lower risk when born to ewes aged three years.  Early 
castration (within the first 60 minutes of life) has also been shown to increase the 
risk of developing WM possibly as a result of delayed ingestion of colostrum 
(Collins and others 1985).  Furthermore, incidence rates may vary considerably 
from year to year which may suggest that combinations of environmental and 
management factors may be important (Collins 1981; Eales and others 1986).   
 
It has been suggested that these factors combined lead to reduced colostrum 
intake increasing the risk of acquiring WM (Eales 1987; King and Hodgson 1991).  
In experimental studies adequate colostrum intake reduces the risk of WMD 
(Hodgson and others 1999; Hodgson and others 1992), however both Collins and 
others (1985) and Eales and others (1986) showed no association with colostrum 
derived IgG in lamb serum.  Watery mouth disease has been reported to be more 
common in lambs born to housed ewes, although it can occur in ewes lambed 
outside (Collins 1981; King and Hodgson 1991; Sargison 2008a), and it is 
hypothesised that wet and insanitary conditions lead to an increased risk of 
ingesting the pathogen by the lamb.  This is corroborated by data from Scott 
(1988), who reported increased incidence over the lambing period in eight flocks, 
and is also supported by data from Binns and others (2002) who showed that after 
adjusting for other confounders those farmers who failed to bed down the 
mothering pens used at lambing daily reported higher mortality rates compared 
to those that did.   
 
Clearly, the epidemiology of WM is poorly understood in terms of the frequency, 
distribution and determinants of disease, indeed we are limited mainly to one 
admirable yet flawed investigation from 1986.  The scant available evidence and 
clinical experience would suggest the disease is widespread and endemic in a 
majority of flocks.  A sound understanding of the epidemiology of WM is required 
to enable its prevention and control and facilitate appropriate targeted treatment 
as opposed to the current situation of unsustainable mass antibiosis.   
 
Treatment 
There have been no well-designed intervention studies and the few reports 
available have been aimed at targeting the perceived aetiopathogenesis.  There 
are two case reports investigating the response to empirical treatment: in Eales 
and others (1986) cases of WM were treated with antibiotics administered 
enterally (neomycin and streptomycin) and parenterally (amoxicillin), 
glucose/electrolyte solution administered by stomach tube, together with not 
feeding milk but leaving the lamb to suck the ewe if and when it recovered.  This 
was an uncontrolled study but was reported to be successful in 89% of cases.  A 
further report investigated the treatment response following amoxicillin plus 
clavulanic acid injection together with intravenous flunixin meglumine and an 
oral rehydration solution.  This protocol was successful in 21 of 23 cases (91.3%) 
(Scott and Gessert 1996).  Other anecdotes include the use of oral flunixin 
meglumine in isolation (Mitchell 1992), paracetamol (acetaminophen) (Nixon 
1991), warm water enemas (Robinson 1981; Shaw 1981), laxatives (Shaw 1981; 
Watt. A. 1980) and metoclopramide in attempt to restore or increase gut motility 
(Mitchell and Linklater 1983; Scott 1988).   
 
It is possible that antibiotic treatment of already bacteraemic lambs may result in 
a more severe endotoxaemia due to the increased release of endotoxin as a result 
of bacterial death.  In two studies: Shenep and others (1985); Shenep and Mogan 
(1984) a rabbit model was used to show that plasma endotoxin concentration 
could increase to much greater levels following the administration of an antibiotic 
compared to a placebo, but this could vary depending on the antibiotic used.  
Clearly, well designed intervention studies are necessary in order to develop an 
evidence base for treated cases with WM, including supportive therapy aimed at 
treating the endotoxaemia and also a particular focus on the selection of particular 
antibiotics and timing and route of administration.   
 
Prevention and Control 
Hodgson and others (1999) clearly demonstrated that lambs fed either colostrum 
or ewe milk replacer with the addition of oral spectinomycin as the first feed were 
prevented from developing WM in a natural infection model compared to lambs 
just fed ewe milk replacer.  In that study, 9/18 lambs developed WM when fed just 
milk replacer but no lambs from the other two groups developed disease.  The use 
of this antibiotic was justified on the basis of its poor absorption from the gut and 
its bacteriostatic activity, in an attempt to reduce the liberation of endotoxin en-
masse from lysed bacteria (Shenep and others 1985; Shenep and Mogan 1984).   
 
On a single farm Eales and others (1986) examined two preventative protocols.  
In the first they administered a combination of neomycin and streptomycin orally 
(n=58) and in the second amoxicillin orally (n=46), with both interventions given 
within 15 minutes of birth.  Both interventions were pseudo-randomly allocated 
and compared to lambs receiving no treatment (n=60 and n=63 respectively).  
Both interventions were shown to prevent WM compared to the control lambs 
(P<0.001 and P<0.05 respectively), however the study is weakened by the lack of 
blinding, the possibility of bias during randomisation and the lack of control 
substance/placebo in the control lambs.  Further analysis using the t test 
suggested that whilst the four farms that used antibiotics prophylactically had 
lower incidence rates compared to those that did not (mean 1.1% (SD 0.47) of 
lambs born, P=0.03), they had relatively high mortality rates in affected cases 
(mean 59.5% (SD 30.0) of cases P<0.001).   
 
Metoclopramide has been used prophylactically as a preventative in a placebo 
controlled study of eight farms.  On four of these farms there was a reduced 
incidence compared with the placebo, however in one farm the association was 
reversed.  In the other three flocks the incidence in both groups was too low for 
comparisons to be made (Scott 1988).   
 
On the basis of these small studies, veterinary advice has included recommending 
adequate colostrum intake, reducing exposure to infection by ensuring clean dry 
bedding and cleaning and disinfecting lambing pens between occupants, and 
administering oral antibiotics prophylactively/metaphylactically within 15 
minutes of birth.  Much of this advice remains sound although the routine 
prescribing of antibiotics for prophylactic/metaphylactic use is now clearly 
unsuitable and irresponsible (Sheep Veterinary Society 2017).   
 
Vaccination 
A vaccine would be an attractive option, however the onset of disease is so rapid 
in clinical cases that a vaccine administered to lambs at birth is unlikely to be 
efficacious.  Vaccinating the ewe would be possible to boost immunoglobulins in 
colostrum if specific E. coli were associated with disease, as has been shown for 
some pathogenic E. coli (Acres and others 1979; Altmann 1983; Cameron and Fuls 
1970; Gregory and others 1983; Morris and others 1980; Pugh and Wells 1985; 
Sojka and others 1978; Wray and others 1983), however this could be 
unsuccessful if lambs still fail to get colostrum.   
 
Alternative strategies for prevention 
Sodium chlorate was shown to reduce the number of generic E. coli in the colon of 
treated lambs compared to controls, although the effect seen was weak (P=0.06) 
possibly due to the low power of the study.  However, this option is unlikely to be 
pursued due to the risks of toxicity (Taylor and others 2012).   
 
Two other intervention strategies worthy of investigation include the use of 
probiotic preparations (Bilková and others 2013; Zhakupova and others 2017) 
and the use of bacteriophages (Johnson and others 2008; Smith and Huggins 
1983).  Currently the normal development of the ovine gastrointestinal 
microbiome is unknown, however fostering the development of a healthy 
microbiome may serve to outcompete pathogenic species or the overgrowth of 
less desirable commensal species.  This has been attempted with some success in 
experimentally reducing the growth of E. coli with the K99 antigen and may 
warrant further investigation (Bomba and others 1997; Timmerman and others 
2004).  Studies of the microbiome would also serve to inform whether the use of 
bacteriophages may be worthy of exploration.  Several studies again looking 
specifically at known pathogenic E. coli have shown promising results in neonatal 
ruminants including lambs (Johnson and others 2008; Smith and Huggins 1983).  
In order to be successful, specific E. coli associated with WM would need to be 
identified in order to investigate possible phage candidates as targeted 
therapeutics.   
 
Conclusions 
The clinical picture of WM appears well described and the pathophysiology has 
been elegantly demonstrated to be attributed to the production of endotoxin, 
probably as a result of undefined, previously considered apathogenic E .coli.  The 
reasons for these agents becoming established and causing disease in lambs are 
unknown although early ingestion from an insanitary environment is plausible.  
However, the pathology and epidemiology are poorly understood in turn 
hampering prevention and therapeutic investigation.  We believe WM to be 
widespread, endemic and largely ignored due to the routine use of prophylactic 
and metaphylactic antibiosis, a state of affairs which needs to be addressed 
immediately.  Given the need to improve animal welfare, improve food security, 
develop farm profitability and reduce antibiotic use in food producing animals, 
there is clearly an urgent need to assess the current incidence of WM, develop a 
rigorous understanding of the farm, animal and environmental determinants of 
disease and develop appropriate and effective non-antibiotic approaches to 
disease prevention and control.  In addition, further investigation using newer 
technologies of the developing microbial communities within the neonatal 
gastrointestinal tract may help determine if there are specific pathogens 
associated or if disease actually occurs due to a deviation from normal physiology 
or the developmental microbiology.  From an animal welfare perspective, well 
designed treatment studies are warranted in order to treat sick cases 
appropriately and effectively.   
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